Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

…, DM Rassl, RC Rintoul, SM Janes, SM Lee, M Forster… - Science, 2014 - science.org
Spatial and temporal dissection of the genomic changes occurring during the evolution of
human non–small cell lung cancer (NSCLC) may help elucidate the basis for its dismal …

Extensive heterogeneity in somatic mutation and selection in the human bladder

…, B Thomas, V Gnanapragasam, N Williams, DM Rassl… - Science, 2020 - science.org
The extent of somatic mutation and clonal selection in the human bladder remains unknown.
We sequenced 2097 bladder microbiopsies from 20 individuals using targeted (n = 1914 …

[HTML][HTML] Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study

…, PL Molyneaux, H Parfrey, DM Rassl… - The Lancet respiratory …, 2017 - thelancet.com
Background Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease with
high mortality, uncertain cause, and few treatment options. Studies have identified a significant …

Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non–small cell lung cancer: a multicenter …

…, M Munavvar, BJ Ng, DM Rassl, M Falzon… - American journal of …, 2012 - atsjournals.org
Rationale: The current management of advanced non–small cell lung cancer (NSCLC)
requires differentiation between squamous and nonsquamous subtypes as well as epidermal …

[PDF][PDF] Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer

…, GJ Doherty, DM Rassl, RC Rintoul, M Signore… - Cancer Cell, 2023 - cell.com
The accumulation of senescent cells in the tumor microenvironment can drive tumorigenesis
in a paracrine manner through the senescence-associated secretory phenotype (SASP). …

ctDNA monitoring using patient-specific sequencing and integration of variant reads

…, JE Abraham, C Caldas, DM Rassl… - Science translational …, 2020 - science.org
Circulating tumor-derived DNA (ctDNA) can be used to monitor cancer dynamics noninvasively.
Detection of ctDNA can be challenging in patients with low-volume or residual disease, …

CD133+ Cancer Stem-like Cells in Small Cell Lung Cancer Are Highly Tumorigenic and Chemoresistant but Sensitive to a Novel Neuropeptide Antagonist

…, N Avlonitis, M Bradley, RC Rintoul, DM Rassl… - Cancer research, 2014 - AACR
Small cell lung cancer (SCLC) is a highly aggressive malignancy with poor survival rates,
with initial responses nearly invariably followed by rapid recurrence of therapy-resistant …

[HTML][HTML] British Lung Foundation/United Kingdom Primary Immunodeficiency Network consensus statement on the definition, diagnosis, and management of …

…, J Jacob, AG Nicholson, DM Rassl… - The Journal of Allergy …, 2017 - Elsevier
A proportion of people living with common variable immunodeficiency disorders develop
granulomatous-lymphocytic interstitial lung disease (GLILD). We aimed to develop a …

[HTML][HTML] Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis

…, A Nair, RD Page, MKB Parmar, DM Rassl… - The lancet regional …, 2021 - thelancet.com
Background The NLST reported a significant 20% reduction in lung cancer mortality with
three annual low-dose CT (LDCT) screens and the Dutch-Belgian NELSON trial indicates a …

[HTML][HTML] Biological basis for novel mesothelioma therapies

…, E Linnane, X Liu, AA Azad, DM Rassl… - British Journal of …, 2021 - nature.com
Mesothelioma is an aggressive cancer that is associated with exposure to asbestos. Although
asbestos is banned in several countries, including the UK, an epidemic of mesothelioma is …